肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
临床试验招募
登录/注册
VIP特权
广告
广告加载中...

文章:

炎症与甲状腺癌:解析血液免疫指标的作用

Inflammation and Thyroid Cancer: Deciphering the Role of Blood Immune Indexes

原文发布日期:19 April 2025

DOI: 10.3390/cancers17081363

类型: Article

开放获取: 是

 

英文摘要:

Background: Inflammation within tumor microenvironments has been correlated to numerous malignancies. This study aims to explore its significance in thyroid cancer (TC). Methods: Retrospective analysis of 157 thyroid carcinomas and 40 benign cases involved initial univariate analysis. The value of neutrophils/value of lymphocytes (NLR), value of platelets/value of lymphocytes (PLR), value of lymphocytes/value of monocytes (LMR), and value of platelets × value of neutrophils/value of lymphocytes (SII) indexes were related to TC characteristics and number and location of involved lymph nodes using χ2or Fischer’s exact tests for categorical variables and Student’st-tests for continuous ones. A 1:1 propensity score matching balanced malignant and benign TC groups based on age, sex, and tumor size was used. Post-matching, a multivariate logistic model integrated sex, age, Central lymph node metastases (CLNM), and SII index. Statistically significant immune index values underwent ROC curve analysis for determining cut-offs. Among the 157 malignant TC, median test and density plots were performed. Results: The SII index emerged as a predictor of malignancy in both univariate and multivariate analyses (p-value = 0.0202). The ROC curve indicated a cut-off SII value of 465.71, (specificity = 58% [95% CI: 0.43–0.73]; sensitivity = 80% [95% CI: 0.68–0.93]). Median SII index values for tumor sizes of 1 and >1 were 522.8 and 654.8, respectively (p-value = 0.016). When central lymph nodes metastases(CLNMs) was considered (CLNM = 0 vs. CLNM > 0), median SII values were 530.7 and 1121.7, respectively (p-value = 0.011). Conclusions: The SII index appears to be a valuable tool in the presence of TC, showing correlations with malignancy, tumor size, and CLNMs.

 

摘要翻译: 

背景:肿瘤微环境中的炎症反应与多种恶性肿瘤的发生发展相关。本研究旨在探讨其在甲状腺癌(TC)中的临床意义。方法:回顾性分析157例甲状腺癌及40例良性病例,首先进行单因素分析。采用χ²检验或Fisher精确检验处理分类变量,Student t检验处理连续变量,分析中性粒细胞/淋巴细胞比值(NLR)、血小板/淋巴细胞比值(PLR)、淋巴细胞/单核细胞比值(LMR)及系统性免疫炎症指数(SII,血小板计数×中性粒细胞计数/淋巴细胞计数)与甲状腺癌临床特征、淋巴结转移数量及部位的相关性。通过1:1倾向评分匹配法,依据年龄、性别及肿瘤大小对恶性与良性甲状腺癌组进行平衡。匹配后,构建包含性别、年龄、中央区淋巴结转移(CLNM)及SII指数的多因素逻辑回归模型。对具有统计学意义的免疫炎症指标进行受试者工作特征(ROC)曲线分析以确定最佳截断值。在157例恶性甲状腺癌中,进行中位数检验及密度分布图分析。结果:单因素及多因素分析均显示SII指数是甲状腺恶性肿瘤的预测因子(p值=0.0202)。ROC曲线确定SII最佳截断值为465.71(特异性=58% [95% CI: 0.43–0.73];敏感性=80% [95% CI: 0.68–0.93])。肿瘤直径≤1 cm与>1 cm组的中位SII值分别为522.8和654.8(p值=0.016)。按中央区淋巴结转移状态分组(CLNM=0 vs. CLNM>0),中位SII值分别为530.7和1121.7(p值=0.011)。结论:SII指数可作为甲状腺癌诊疗中有价值的辅助指标,其与恶性肿瘤风险、肿瘤大小及中央区淋巴结转移状态均显示出显著相关性。

 

原文链接:

Inflammation and Thyroid Cancer: Deciphering the Role of Blood Immune Indexes

广告
广告加载中...